Mentor: Dr. Hui Hu, Associate Professor, Department of Microbiology, School of Medicine, University of Alabama at Birmingham. E-mail: Immhulab@gmail.com
A new Postdoctoral position is now open in the research group of Dr. Hui Hu. The research project aims to develop infectious disease and novel autoimmune disease models, and study the molecular mechanisms underlying several new pathways in CD8+ T cell effector and memory responses and CD4+ T follicular helper cell differentiation (Blood 115:510 (2010), Nat Immunol 12:544(2011), Nat Immunol (2014, in press)).
The postdoctoral candidate will have recently acquired a Ph.D. and/or M.D. preferably in immunology with technique expertise in flow cytometry and molecular biology. Strong background in transcriptional regulation and/or signaling pathways is desirable. Candidate should be self-motivated and career oriented.
To apply, please submit your curriculum vitae and cover letter including names and contact information of three references to, Hui Hu, Ph.D., Associate Professor, Department of Microbiology, School of Medicine, UAB, E-mail: Immhulab@gmail.com
Postdocs in UAB News
Longtime VP for Research and Economic Development Richard B. Marchase, Ph.D., plans to retire at the end of 2016. During his tenure, UAB annual research expenditures grew from $331 million to $510 million.
Researchers have proposed a model that resolves a seeming paradox in one of the most intriguing areas of the brain, exploring how immature granule cells in the dentate gyrus appear able to enhance pattern separation due to lesser synaptic connectivity than mature cells.
Palliative care helps patients get the most out of life, whether they’re newly diagnosed, a survivor, or nearing the end of their journey. UAB’s palliative care pioneers provide a fresh look at the fast-growing specialty and its emphasis on listening, choices, patient goals, and quality of life.
UAB Research News
AIMTech’s ResistX treadmill will make its debut at the American College of Sports Medicine’s annual conference.
The UAB Cancer Center has received a $29 million National Cancer Institute renewal grant and is re-designated as “comprehensive” with an outstanding rating as a leader in advancing cancer research and care.